Title:
医薬組成物
Document Type and Number:
Japanese Patent JP2009510099
Kind Code:
A
Abstract:
A novel pharmaceutical composition comprising the NK3 receptor antagonist talnetant, povidone, erythritol and a surfactant, and a process for its preparation are disclosed. The use of erythritol as soluble filler in the preparation of a stable pharmaceutical composition is disclosed.
More Like This:
| JP5149470 | Factor VIII formulation without novel albumin |
| WO/2002/009814 | NEW USE OF LIPASE INHIBITORS |
| JPS60161918 | ENDERMIC ADMINISTRATION OF METOCLOPRAMIDE |
Inventors:
Jeffrey Blum
Shisei Gebrekidan
Renan Pan
Shisei Gebrekidan
Renan Pan
Application Number:
JP2008533660A
Publication Date:
March 12, 2009
Filing Date:
September 28, 2006
Export Citation:
Assignee:
SMITHKLINE BEECHAM CORPORATION
International Classes:
A61K47/10; A61K9/00; A61K9/14; A61K9/20; A61K9/48; A61K31/192; A61K31/4704; A61K31/549; A61K47/20; A61K47/26; A61K47/32; A61P1/04; A61P1/08; A61P1/14; A61P3/04; A61P9/00; A61P11/00; A61P11/06; A61P15/10; A61P21/04; A61P25/00; A61P25/02; A61P25/06; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/26; A61P25/28; A61P25/30; A61P25/32; A61P25/34; A61P25/36; A61P29/00; A61P43/00
Attorney, Agent or Firm:
Mitsuo Tanaka
Hiroshi Yamazaki
Tadayuki Motoyama
Kenji Tomita
Hiroshi Yamazaki
Tadayuki Motoyama
Kenji Tomita